Figure 1From: The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus Physiological mechanisms implicated in arterial stiffness lowering effects with sodium glucose cotransport-2 inhibition. Back to article page